9
Views
3
CrossRef citations to date
0
Altmetric
Original Article

A double-blind comparison study between penfluridol and perphenazine in acute schizophrenic patients

Pages 384-391 | Published online: 12 Jul 2009

References

  • Eklund K. L. Perfenazin enantat och perfenazin-tabletter. En dubbel-blind jämförelse vid schizofrena psykoser. Nord. Psykiat. T. 1972; 26: 474–482
  • Floru L., Zurbon R. Stationäre Erfahrung mit einem oralen Langzeit-Neuroleptikum: Penfluridol. Med. Welt. 1973; 24: 600–603
  • Gallant D. M., Mielke D. H., Spirtes M. A., Swanson C., Bost R. Penfluridol: An efficacious long-acting oral antipsychotic compound. Amer. J. Psychiat. 1974; 131: 699–702
  • Crozier M. L. The third revolution in psychiatry — A summary. The future of pharmacotherapy new drug delivery systems, F. J. Ayd, 1973; 97–108
  • Overall J. E., Gorham D. R. The brief psychiatric rating scale. Psychol. Rep. 1962; 10: 799–812
  • Van Praag H. M., Scbut T., Dols L., Van Schilfgaarden. R. Controlled trial of penfluridol in acute psychosis. Brit. Med. J. 1971; ii: 710–713
  • Seeman P., Lee T. Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975; 188: 1217–1219
  • De Smedt R., Rodrigus E., Debandt R., Brugmans J. Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up. J. Clin. Pharmaco. 1970; 10: 207–211

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.